IP Forecast: Fed. Circ. To Mull Narcan Patents
Emergent BioSolutions' grip on its blockbuster opioid overdose medication Narcan is at stake in a patent case that reaches the Federal Circuit on Monday....To view the full article, register now.
Already a subscriber? Click here to view full article